Previous Close | Open | Close* |
---|---|---|
19.14 | 17.95 | 18.15 |
Market Cap | Dividend Yield (Annualized) |
---|---|
AUD 10.478B | 1.59% |
Day Range |
---|
17.58L 18.34 H |
52 WEEK HIGH LOW |
---|
17.14L 33.01 H |
Last Trade | 18.15 |
---|---|
Change% | -5.1724 |
52 W H/L | 33.010/17.140 |
EBITDA | 605.1M |
NPAT After Abnormal Items | 376.9M |
Equity | 1.68B |
ROE% | 22.44% |
Total Liabilities | 427.3M |
Total Revenue | 1.682B |
Cash and Cash Equivalents | 89.9M |
Share price | 18.15 |
---|---|
Market Cap | 10.478B |
Price/Gross Cash Flow | 31.21 |
Dividend Yield Excluding Special | 1.59% |
Ending Shares | 577.406M |
52-Week Range | 33.010-17.140 |
Gross DPS (AUD) | 0.3882 |
Gross Dividend Yield (Annualized) | 1.59% |
Earnings Yield | 3.070 |
Net Tangible Asset (NTA) | 2.76 |
P/E ratio | 32.573 |
Sector P/E | -- |
EPS | 65.00 |
EV/EBITDA | 23.36 |
Net Profit Margin (%) | 22.95% |
Gross Cash Flows Per Share | 0.78 |
Net Gearing | 0.86% |
Sales Per Share | 2.83 |
Book Value Per Share | 2.91 |
Fisher and Paykel Healthcare Corporation Ltd (ASX: FPH) is a health care company that was listed in 2001 and is based in Maurice Paykel Place, East Tamaki, Australia. It is a medical devices and systems leader in the world and the products are sold in more than 120 countries. Particularly, the group caters to the respiratory and acute care, and treatment of obstructive sleep apnea.
15 Maurice Paykel Place, East Tamaki, AUSTRALIA,
Ex-Date | Net Dividend | Frank Flag | Period End Date | Type | Payable |
---|
Event Type | Event Date | Event Year |
---|---|---|
Report (Annual) | 2023-05-24 | 2023 |
Report (Prelim) | 2023-05-24 | 2023 |
Report (Interim) | 2022-11-24 | 2022 |
AGM | 2022-08-24 | 2022 |